BNTX BioNTech Pharma Total Debt to Capital
BioNTech SE (BNTX) management is pragmatically allocating capital toward the expansion of oncology research and development. This debt-to-equity chart demonstrates financial stability, where 0.02 represents the most recent level. Its status as a global leader in mRNA therapy guarantees market confidence, while a network of sterile plants in Germany ensures the stable production of innovative drugs.
Analytical breakdowns and data insights for company BioNTech Pharma (BNTX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:BNTX - BioNTech
Fundamental analysis of the debt load allows for the minimization of risks when assessing the financial stability of BioNTech SE (BNTX). A conservative approach to borrowing correlates with strict adherence to environmental standards during the construction of BioNTech SE (BNTX) plants. The ratio of total liabilities to equity measures the share of borrowed capital within the balance sheet structure. Low values for this indicator confirm the business's independence from creditors. Such a strategy guarantees asset preservation during market shocks.
Main competitors
Debt to Equity argenx ARGX|Aggregate Debt to Equity Abivax|ADMA Bio (ADMA) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio Protagonist Corp (PTGX)|Total Debt to Capital IMVT (Immunovant, Inc.)|kiniksa.com - Total Debt to Capital|Debt to Equity Grifols (GRFS)|ADPT: All Debt to Shareholders' Equity Ratio|CLDX (Celldex) - Debt to Equity|Aurinia Corp (AUPH) - Total Debt to Equity Ratio|BCRX (BioCryst) - Total Debt to Capital|Total Debt to Capital veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio Pharvaris NV (PHVS)|Total Debt to Capital ABCL|Tourmaline - Total Debt to Capital Coefficient|PGEN: Debt to Equity|PHAR: Total Debt to Equity Ratio|NKTR (Nektar Therapeutics Inc.) - Debt to Equity|Total Debt to Equity Ratio Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Total Debt to Equity Ratio|Total Debt to Capital IMNM|Debt to Equity Gossamer Bio, Inc. GOSS|Debt to Equity Ratio kalvista.com (KALV)|SEPN: Total Debt to Capital|Debt to Capital Pieris Pharma PVLA|SVRA - Total Debt to Capital|RIGL - Debt to Equity|AnaptysBio, Inc. - Total Debt to Capital|ATXS (astriatx.com) - Total Debt to Capital Coefficient|Debt to Equity ENGN (enGene)|Debt to Capital RAPT|Debt to Equity Aerovate Therapeutics Inc JBIO|Debt to Equity Ratio Aclaris Therapeutics, Inc ACRS|Total Debt to Equity Ratio Kyverna Therapeutics (KYTX)|Aggregate Debt to Capital tizianalifesciences.com TLSA|CABA (Cabaletta Bio) - Total Debt to Capital|VTYX - Debt to Capital|THTX (Theratechnologies Inc) - Total Debt to Capital|Avalo Therapeutics Inc (AVTX) - Total Debt to Equity Ratio|ELDN - Total Debt to Capital|All Debt to Shareholders' Equity Ratio agenusbio.com (AGEN)|Climb Bio (CLYM) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio ZURA (Zura Bio Ltd)|Debt to Equity ATYR|Total Debt to Capital Coefficient Adagene Inc ADAG|IMA (Ikena Oncology, Inc.) - Total Debt to Capital|STTK - Debt to Capital|equilliumbio.com (EQ) - Total Debt to Capital|CNTB (Connect Biopharma Holdings Limited) - Debt to Equity|Debt to Equity Immunic Therapeutics (IMUX)|Debt to Equity Ratio Atara Biotherapeutics Inc (ATRA)|Total Debt to Equity Ratio InflaRx N.V.|Aggregate Debt to Capital x4pharma.com XFOR|ACET - Total Debt to Equity Ratio|Celularity Inc - Debt to Equity Ratio|Debt to Equity INmune Bio Corp|BRNS - Aggregate Debt to Equity|Total Debt to Capital Kezar Life Sciences KZR|sabbiotherapeutics.com (SABS) - All Debt to Shareholders' Equity Ratio|AKTX (Akari Therapeutics Plc) - Total Debt to Capital|Total Debt to Capital ENLV|Q32 Bio Inc. (QTTB) - Debt to Equity|All Debt to Shareholders' Equity Ratio GOVX (GeoVax Corp)|Edesa Biotech, Inc. - Debt to Equity|Total Debt to Equity Ratio ibioinc.com IBIO|Carisma Tx - Total Debt to Capital|XTL Biopharmaceuticals Ltd (XTLB) - Total Debt to Capital|Total Debt to Equity Ratio boltbio.com BOLT|HCW Biologics (HCWB) - All Debt to Shareholders' Equity Ratio|APVO: Total Debt to Capital|Total Debt to Capital Coefficient AIM|Debt to Equity ADTX (Aditxt)|Total Debt to Equity Ratio GRI (GRI Bio Inc)|XORTX - Debt to Equity|HIND - Total Debt to Equity Ratio|Revelation Biosciences - Total Debt to Equity Ratio|INDP: Total Debt to Capital|Debt to Equity Scinai Immunotherapeutics Ltd.|CalciMedica (CALI) - Debt to Equity Ratio|Total Debt to Capital AFMD (Affimed NV)|Debt to Capital Allakos Therapeutics|Total Debt to Capital HOOKIPA Pharma Inc. (HOOK)|Debt to Equity igmbio.com (IGMS)|Total Debt to Capital ITOS|Ocean Biomedical Inc - Total Debt to Capital Coefficient|TCBP (TC BioPharm (Holdings) PLC) - Debt to Equity|THRD: Debt to Capital